发布时间:2019-08-03 23:46 原文链接: InfluenceofRasandRhoproteinsonG1toSTransition

The cell cycle transition from G1 to S phase is a key regulatory point in the cell cycle. This transition is regulated by the checkpoint kinase cdk2 that activates the G1 to S transition when it is associated with cyclin E. Cdk2/Cyclin E causes the G1 to S transition through phosphorylation of the tumor suppressor Rb, releasing the transcription factor E2F-1. Other pathways acting through Rac, Ras and Rho also regulate the G1 to S transition. Ras regulates cyclin D1 expression to affect the G1 to S transition. Transforming forms of Ras or Raf induce cyclin D1 expression and cause early entry into S phase. Signaling from Ras to Raf to MEK to ERKs induces Cyclin D1 expression, allowing Cyclin D1 to complex with Cdk4 and Cdk6 and phosphorylate Rb. Rac-1 and PAK appear to induce Cyclin D1 expression and induce the G1 to S transition primarily through activation of NF-kB to activate the Cyclin D1 promoter. Rho activates cdk2 and also inhibits p21 and p27 to induce cyclin D1 and stimulate the G1 to S transition. Rho represses p21 expression to block p21 induction by Ras and to allow Ras induced progression from G1 to S. Cells that lack p21 do not require Rho for Ras to induce cell cycle progression from G1 to S phase. The cooperative action of Ras, Rac and Rho to induce Cyclin D1 expression is a key component of oncogenic transformation.

Contributor:

REFERENCES: Baldin, V. et al. (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev (5), 812-21 Dafna Bar-Sagi and Alan Hall. (2000) Ras and Rho GTPases: A Family Reunion. Cell, Vol. 103, 227-238 Frost, Jeffrey et al. (2000) Stimulation of NFkB Activity by Multiple Signaling Pathways Requires PAK1. J. Biol Chem 275(26):19693-99 Guttridge, D.C. et al. (1999) NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19(8), 5785-99 Hirai, A. et al. (1997) Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells. J Biol Chem. 272(1), 13-6. Kerkhoff, E., Rapp, U.R. (1997) Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. Mol Cell Biol 17(5), 2576-86 Liberto, M., Cobrinik, D., Minden, A. (2002) Rho regulates p21(CIP1), cyclin D1, and checkpoint control in mammary epithelial cells. Oncogene 21(10), 1590-9 Tanaka, T. et al. (1998) Activation of cyclin-dependent kinase 2 (Cdk2) in growth-stimulated rat astrocytes. Geranylgeranylated Rho small GTPase(s) are essential for the induction of cyclin E gene expression. J Biol Chem. 273(41), 26772-8. Welsh, Catherine et al. (2001)Timing of cyclin D1 expression within G1 phase is controlled by Rho. Nature Cell Bio vol 3; Nov 2001: 950-57


相关文章

艾立本科技UHPLCTQMSG1申报ANTOP精准卫士联用分析仪奖,大众评审诚邀投票!

2025年ANTOP奖评审正在火热进行中。由成都艾立本科技有限公司申报的“ANTOP精准卫士联用分析仪奖”进入大众评审阶段。在此诚邀业界各位老师为成都艾立本科技有限公司的UHPLCTQMSG1超高效液......

美国TO设备助阵,第六届上海市力学竞赛团体赛圆满成功

2024年11月9日,由上海市力学学会主办、同济大学承办的第六届上海市大学生力学竞赛团体赛在同济大学举行。来自同济大学、上海交通大学、复旦大学、华东师范大学、上海大学、上海工程技术大学、上海师范大学、......

科学家将人工智能技术成功用于蛋白质复合物结构预测

蛋白质作为构成人体组织器官的支架和主要物质,在人体生命活动中起着重要作用。蛋白质的相互作用能产生许多效应,如形成特异底物作用通道、生成新的结合位点、失活、作用底物专一性和动力学变化等,细胞的代谢、信号......

发力癌症分子病理诊断,无锡臻和全资收购TissueofOrigin®

2021年9月9日,无锡臻和生物科技有限公司(以下简称“臻和科技”)与美国VyantBio公司签署TissueofOrigin®(以下简称“TOO®”)全球权益和ZL转让协议,全资收购这款唯一获FDA......

这3个杂志撤回中国学者249篇文章,包含上交、中山等名校

2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同时撤回了中国学者49篇文章。从2019年开始,Journalo......

RAS靶点的药物的研发进程的梳理盘点

RAS是肿瘤患者中最常见的致癌基因之一,目前包括KRAS、NRAS以及HRAS三种亚型。其中,NRAS突变多见于黑色素瘤和急性骨髓性白血病,HRAS突变多见于膀胱癌和头颈癌,而KRAS突变比其他两种更......

RAS靶点的药物的研发进程的梳理盘点

RAS是肿瘤患者中最常见的致癌基因之一,目前包括KRAS、NRAS以及HRAS三种亚型。其中,NRAS突变多见于黑色素瘤和急性骨髓性白血病,HRAS突变多见于膀胱癌和头颈癌,而KRAS突变比其他两种更......

RAS突变可激活胰腺癌细胞的巨胞饮作用?

在一项新的研究中,来自美国纽约大学医学院的研究人员揭示了一种通过劫持从周围环境吸收营养物的过程来帮助胰腺癌细胞避免挨饿的机制。他们解释了RAS基因发生的突变不仅促进在90%的胰腺癌患者中观察到的异常生......

RAS突变可激活胰腺癌细胞的巨胞饮作用?

在一项新的研究中,来自美国纽约大学医学院的研究人员揭示了一种通过劫持从周围环境吸收营养物的过程来帮助胰腺癌细胞避免挨饿的机制。他们解释了RAS基因发生的突变不仅促进在90%的胰腺癌患者中观察到的异常生......

肿瘤治疗的强心剂,中国学者开发肿瘤治疗新策略

磷酸甘油酸突变酶1(PGAM1)通过其代谢活性以及与其他蛋白质(例如α平滑肌肌动蛋白(ACTA2))的相互作用,在癌症代谢和肿瘤进展中起关键作用。变构调节被认为是发现针对PGAM1的高选择性和有效抑制......